Published Date: 13 Mar 2023
Intravenous (IV) ketamine is effective in adults resistant to depression. The response was similar to that seen in younger patients, two new studies show.
Read Full NewsEurope will need to rethink how it values and pays for innovative medicines or risk losing manufacturing investments and clinical trials, the head of Europe's pharmaceutical industry lobby said.
Patients, doctors, and other healthcare professionals who spoke with KFF Health News say the effort has created confusion, errors, long wait times, and stress.
Research on creatine supplementation has moved from the gym to the brain lab, leading neurologist Heidi Moawad to review the data on creatine’s potential for improving cognitive health.
Patients with MASLD often underreport alcohol use and even modest intake can block improvement. Drs VanWagner and Ajmera share practical tools to quantify intake, spot MetALD, and counsel patients effectively.
MASLD is a silent condition and labs may look normal. Drs VanWagner and Shubrook walk through who to screen, how to use FIB-4, and when primary care can manage MASLD without a specialist.
Palbociclib is now the first CDK4/6 inhibitor approved for metastatic disease regardless of HER2 status.
Mirvetuximab has come up short in the first randomized trial testing an antibody-drug conjugate plus standard carboplatin for patients with platinum-sensitive ovarian cancer.
1.
Worse Outcomes After Esophagectomy at Private Equity-Owned Hospitals
2.
Adding Daratumumab to VRd Boosts MRD Negativity in Transplant-Ineligible Myeloma
3.
GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium
4.
Prostate cancer relapse after radiotherapy is strongly predicted by biological markers.
5.
Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer
1.
Giant Sebaceous Cyst of the Scalp Mimicking a Soft Tissue Tumor: A Case Study
2.
Refining AML Survival: Prognostic Factors, Therapies, and Stem Cell Strategies Reviewed
3.
ADCs and Bispecific Antibodies: Advancing the Future of Cancer Immunotherapy
4.
Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care
5.
Revolutionizing Thyroid Cancer: Advances in Molecular Genetics and Personalized Treatment Approaches
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
5.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation